CellFX System for the Treatment of Cutaneous Non-Genital Warts

Status Completed

Clinical Trial Summary

This prospective, non-randomized, multicenter pivotal study is designed to evaluate the safety and effectiveness of the CellFX System in patients with cutaneous non-genital warts on all areas of the body, excluding the face.

Clinical Trial Description

The study will enroll healthy adult subjects with a minimum of two cutaneous non-genital warts, excluding the face, with each wart lesion not exceeding 10 x 10mm. One of the warts for each subject will be untreated and will serve as the subject's internal control. Macrophotography of all study warts will be captured along with Investigator assessments using the Wart Measurement Scale (WMS) and lesion measurements for wart reduction. All subjects will be followed at 7, 30, 60, 90 and 120-days post-initial CellFX treatment. All wart lesions are eligible for re-treatment up to 3 times over the course of the study. Adverse events will be documented. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04554394
Study type	Interventional
Source	Pulse Biosciences, Inc.
Contact
Status	Completed
Phase	N/A
Start date	July 17, 2019
Completion date	December 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01757392` - Candin Safety & Efficacy Study for the Treatment of Warts	Phase 2
Completed	`NCT00973856` - Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands	N/A
Completed	`NCT02902822` - Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo	N/A
Withdrawn	`NCT00546611` - The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)	Phase 1
Completed	`NCT00117871` - Study With a Topical Gel to Treat Common Warts in Adults	Phase 2
Completed	`NCT04278573` - Intralesional Vitamin D Injection for Treatment of Common Warts	Phase 2
Completed	`NCT02231879` - Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome	Phase 2/Phase 3
Completed	`NCT06309420` - Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts	N/A
Not yet recruiting	`NCT05617950` - Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts	N/A
Not yet recruiting	`NCT05616078` - Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts	N/A
Recruiting	`NCT01712295` - 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts	Phase 4
Active, not recruiting	`NCT00254280` - Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial	N/A
Completed	`NCT04781244` - Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment	N/A
Completed	`NCT01101750` - Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?	Phase 4
Completed	`NCT03487549` - Cantharidin and Occlusion in Verruca Epithelium	Phase 2
Recruiting	`NCT05625633` - Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts	Phase 2/Phase 3
Completed	`NCT02393417` - Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)	Phase 2
Completed	`NCT01808443` - Efficacy of Laser Versus Cryotherapy in the Treatment of Warts	N/A
Completed	`NCT00116675` - Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects	Phase 2
Completed	`NCT00116662` - An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects	Phase 2